First Dose of Tafolecimab Linked to Probable Acute Diarrhea in Case Report
A case report describes a 51-year-old man who developed probable acute diarrhea hours after receiving his first subcutaneous dose of ...
A case report describes a 51-year-old man who developed probable acute diarrhea hours after receiving his first subcutaneous dose of ...
A new computationally guided assay enables rapid detection of citalopram in water and dietary supplements with high specificity.
A new study shows that subcutaneous administration of the monoclonal antibody CSX-1004 provides fentanyl overdose protection comparable to intravenous dosing ...
Weill Cornell Medicine has received more than $635,000 in first-year funding from the NIH's stroke and neurology institute to refine ...
A new study shows that trehalose crystallization during freeze-drying, which requires prolonged annealing and high sugar content, creates inhomogeneity that ...
A trial-based economic evaluation found siltartoxatug achieved far higher trial-defined antibody response rates than human tetanus immunoglobulin in Chinese adults ...
A new study reports that soluble CD161 is elevated in tuberculosis patients, especially those with radiographically severe disease, and that ...
A single 105 mg dose of the long-acting antibody clesrovimab, recently approved in the USA and EU, provides durable protection ...
Vunakizumab, a new anti-IL-17A monoclonal antibody, is approved in China for adults with moderate-to-severe chronic plaque psoriasis after phase 3 ...
The IL-23 blocker guselkumab significantly reduced disease severity compared with placebo in children and adolescents with moderate-to-severe plaque psoriasis in ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine